Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT01682239
Other study ID # EC 023/2012
Secondary ID
Status Enrolling by invitation
Phase N/A
First received September 6, 2012
Last updated September 7, 2012
Start date September 2012
Est. completion date August 2015

Study information

Verified date September 2012
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority Austria: Agency for Health and Food Safety
Study type Interventional

Clinical Trial Summary

Chronic right ventricular apical pacing has been associated with negative hemodynamic effects. Clinical outcome of right ventricular pacing can be influenced by multiple factors. An important factor seems to be optimal lead positioning. Data regarding left ventricular function impaired by lead positioning is insufficient. The aim of the present study therefore is to compare right ventricular apical pacing (RVAP) with right ventricular septal pacing (RVSP). Outcome measurements are echocardiographic features, magnetic resonance imaging and clinical outcome.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 24
Est. completion date August 2015
Est. primary completion date August 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion criteria:

- patients with dysrhythmia requiring dual-chamber pacemaker implantation

- planed MRI-pacemaker implantation (Accent MRI System,St. Jude Medical)

- age between 18-90 years

- no absolute pacemaker dependence

- no present heart failure or any significant coronary heart disease (exclusion by anamnesis and echocardiography - LVH <15mm, LV EF>50%)

- no previous myocardial infarction or significant coronary artery disease

- life expectancy > 1 year

- patients willing to participate in follow-up

Exclusion criteria:

- Contraindications for MRI (Brain aneurysm clips, artificial heart valves, artificial joints, vascular stents)

- Any contraindication for surgery

- Absolute pacemaker dependence

- Claustrophobia

- GFR<30ml/min/1,73m2

- Allergy to contrast agent

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Late Complication From Cardiac Pacemaker Implantation

Intervention

Other:
RVAP
In this arm pacemaker leads will be placed in the RV apex.
RVSP
In this arm pacemaker leads will be placed in the RV septum.

Locations

Country Name City State
Austria Department of Cardiac Surgery, MUV Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

References & Publications (3)

Beinart R, Nazarian S. MRI-Conditional Cardiac Implantable Electronic Devices: What's New and What Can We Expect in the Future? Curr Treat Options Cardiovasc Med. 2012 Oct;14(5):558-64. doi: 10.1007/s11936-012-0197-2. — View Citation

Cano O, Osca J, Sancho-Tello MJ, Sánchez JM, Ortiz V, Castro JE, Salvador A, Olagüe J. Comparison of effectiveness of right ventricular septal pacing versus right ventricular apical pacing. Am J Cardiol. 2010 May 15;105(10):1426-32. doi: 10.1016/j.amjcard.2010.01.004. Epub 2010 Mar 30. — View Citation

Inoue K, Okayama H, Nishimura K, Saito M, Yoshii T, Hiasa G, Sumimoto T, Inaba S, Suzuki J, Ogimoto A, Funada J, Higaki J. Right ventricular septal pacing preserves global left ventricular longitudinal function in comparison with apical pacing: analysis of speckle tracking echocardiography. Circ J. 2011;75(7):1609-15. Epub 2011 May 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Ejection Fraction As primary endpoint the difference of ventricular function in both groups will be taken. Therefore the Ejection Fraction is measured in cardiac MRI and Echocardiography. There may be a different development of contraction, whether the lead is placed in the ventricular apex or the ventricular septum. 6 month Yes